0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Varicella Vaccine Licensing in 18 to 24 Months?

Charles Marwick
JAMA. 1987;258(22):3215-3216. doi:10.1001/jama.1987.03400220013003.
Text Size: A A A
Published online

ABSTRACT

PRELICENSING STUDIES with the experimental live-virus chickenpox vaccine had been going well. The manufacturer, Merck Sharp & Dohme, West Point, Pa, decided to start making the vaccine in quantity.

The first production lots of any new unlicensed vaccine also are for investigational use, including testing in additional human trials. At this point, a problem emerged. In the volunteers with leukemia who were given this production vaccine, there were more frequent vesicular lesions when compared with patients with leukemia who had received the research vaccine. The difference was statistically significant.

Even though there was no increase in adverse effects in normal subjects and no serious reactions occurred even in subjects with leukemia, Merck stopped trials with the vaccine while the problem was investigated. That was in January 1986.

Almost 18 months later, after extensive review of all the clinical data and of the steps involved in making both the earlier research

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();